Amgen Wins UPC Appeal To Revive Cholesterol Drug Patent
Amgen has persuaded an appeals panel at the Unified Patent Court to restore its patent for cholesterol-lowering drug Repatha, overturning a previous victory for rival drugmakers Sanofi and Regeneron....To view the full article, register now.
Already a subscriber? Click here to view full article